Literature DB >> 7963425

Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome.

S Pelletier1, B Landi, J C Piette, P Ekert, A Coutellier, C Desmoulins, J P Fadlallah, S Herson, D Valla.   

Abstract

In a prospective study of 22 patients with non-tumorous Budd-Chiari syndrome, four were found to have the antiphospholipid syndrome with no other cause of hepatic vein thrombosis. All four patients were young women. The antiphospholipid syndrome was secondary to systemic lupus in one case, to a "lupus-like disease" in another, and apparently primary in the remaining two cases. Two patients died. The other two are in good health on chronic oral anticoagulation. In our experience, the antiphospholipid syndrome is a frequent cause, after myeloproliferative disorders, of non-tumorous Budd-Chiari syndrome. In such patients, long-term anticoagulation may prevent recurrence or extension of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963425     DOI: 10.1016/s0168-8278(94)80140-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Essential thrombocytosis and antiphospholipid antibody syndrome causing chronic Budd-Chiari syndrome.

Authors:  Dinesh Yadav; Jagdish Chandra; Sunita Sharma; Varinder Singh
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

2.  Budd-Chiari syndrome: a case with a combination of hepatic vein and superior vena cava occlusion.

Authors:  Yoshio Araki; Chikara Sakaguchi; Izumi Ishizuka; Masaya Sasaki; Tomoyuki Tsujikawa; Shigeki Koyama; Akira Furukawa; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

3.  Abdominal pain, nausea, vomiting, and ascites in a 14-year-old girl with systemic lupus erythematosus: Answers.

Authors:  Ahmet Taner Elmas; YılmazYilmaz Tabel; Ayşe Selimoğlu; Şenay Kenç; Ramazan Kutlu
Journal:  Pediatr Nephrol       Date:  2018-09-05       Impact factor: 3.714

4.  Factor V Leiden related Budd-Chiari syndrome.

Authors:  P Deltenre; M H Denninger; S Hillaire; M C Guillin; N Casadevall; J Brière; S Erlinger; D C Valla
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Prothrombin 20210G/A mutation in two patients with mesenteric ischemia.

Authors:  A Balian; A Veyradier; S Naveau; M Wolf; S Montembault; V Giraud; E Borotto; C Henry; D Meyer; J C Chaput
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

6.  Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.

Authors:  A E Mahmoud; E Elias; N Beauchamp; J T Wilde
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

Review 7.  Budd-Chiari syndrome/hepatic venous outflow tract obstruction.

Authors:  Dominique-Charles Valla
Journal:  Hepatol Int       Date:  2017-07-06       Impact factor: 6.047

8.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.

Authors:  S Hillaire; E Bonte; M-H Denninger; N Casadevall; J-F Cadranel; D Lebrec; D Valla; C Degott
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 9.  Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature.

Authors:  M Sebastiani; C U Manzini; F Campomori; A Spinella; C Vacchi; D Giuggioli; D Giuggoli; F Schepis; C Ferri
Journal:  Clin Rheumatol       Date:  2013-03-13       Impact factor: 2.980

10.  Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome.

Authors:  Kohtaro Toyama; Masamitsu Karasawa; Arito Yamane; Hiromi Koiso; Akihiko Yokohama; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Ken Sato; Hitoshi Takagi; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.